Consumer — D&A

Business Segments · D&A

Year-over-year, this metric declined by 100.0%, from $95.75M to $0.00. Over 3 years (FY 2021 to FY 2024), Consumer — D&A shows a downward trend with a -100.0% CAGR.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2017
Last reportedQ4 2024
Rolls up toD&A

How to read this metric

Higher levels relative to revenue may indicate an asset-heavy business model or recent significant capital investments that are now being expensed.

Detailed definition

The non-cash expense allocated to the Consumer Health segment to account for the gradual wear and tear of physical asset...

Peer comparison

Standard across all industries; comparable to segment-level D&A reported by any company with distinct operating segments.

Metric ID: jnj_segment_consumer_health_depreciation_and_amortization

Historical Data

4 years
 FY'21FY'22FY'23FY'24
Value$785.00M$759.00M$383.00M$0.00
YoY Change-3.3%-49.5%-100.0%
Range$0.00$785.00M
CAGR-100.0%
Avg YoY Growth-51.0%
Median YoY Growth-49.5%
Current Streak3+ years decline

Frequently Asked Questions

What is Johnson & Johnson's consumer — d&a?
Johnson & Johnson (JNJ) reported consumer — d&a of $0.00 in Q4 2024.
How has Johnson & Johnson's consumer — d&a changed year-over-year?
Johnson & Johnson's consumer — d&a decreased by 100.0% year-over-year, from $95.75M to $0.00.
What is the long-term trend for Johnson & Johnson's consumer — d&a?
Over 3 years (2021 to 2024), Johnson & Johnson's consumer — d&a has grown at a -100.0% compound annual growth rate (CAGR), from $785.00M to $0.00.
What does consumer — d&a mean?
The periodic cost assigned to the wear and tear of assets used by the Consumer Health segment.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.